News

Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...
The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...
Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is ...
Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...
The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...
Repertoire Immune Medicines will get $35 million upfront, and possibly $730 million more, in a deal to help Roche’s Genentech ...
HHS Secretary Robert F. Kennedy Jr. is mulling removing the Covid-19 vaccine from the recommended childhood vaccine schedule.
Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T-cell-targeted ...
Roche has picked up a CE Mark approval in the EU for an artificial intelligence algorithm that can help doctors decide whether patients presenting with acute chest pain are having a heart attack.
Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...
The commitment will include new, state-of-the-art R&D facilities as well as new or expanded manufacturing sites in multiple ...
With the threat of pharmaceutical tariffs hanging over the biopharmaceutical industry, Roche is the latest addition to a ...